뒤로
VIA Pharmaceuticals Inc (VIAP) 수입
VIAP 주가 차트
VIAP 수입
VIA Pharmaceuticals Inc
$0
0%
$0
종가: Mar 27, 16:00:00 GMT-4
$0
0%
$0
애프터마켓: Mar 27, 20:00:00 GMT-4
아직 데이터 없음Earnings FAQ
VIAP의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
VIA Pharmaceuticals Inc VIAP의 지난 분기 매출 실적은 어땠나요?
VIA Pharmaceuticals Inc의 매출 추정치는 얼마인가요?
VIA Pharmaceuticals Inc의 수익 품질 점수는 얼마인가요?
VIA Pharmaceuticals Inc는 언제 수익을 보고하나요?
VIA Pharmaceuticals Inc의 예상 수익은 얼마인가요?
VIA Pharmaceuticals Inc은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$0.0005
시가
$0
일일 범위
$0 - $0.0005
52주 범위
$0 - $0.0005
거래량
700
평균 거래량
0
배당수익률
--
EPS(TTM)
-0.47
시가총액
$10.2K
VIAP란 무엇인가요?
VIA Pharmaceuticals, Inc. is a biotechnology company, which engages in the development of compounds for the treatment of cardiovascular diseases. The company is headquartered in San Francisco, California and currently employs 6 full-time employees. The company went IPO on 2000-04-18. The Company’s lead compound, VIA-2291, targets an unmet medical need of reducing atherosclerotic plaque inflammation, which is an underlying cause of atherosclerosis and its complications. Atherosclerosis is a cardiovascular disease that results from chronic inflammation and the build-up of plaque in arterial blood vessel walls. The Company’s clinical development strategy integrates several technologies to provide clinical proof-of-concept, as early as possible in the clinical development process. These technologies include the measurement of biomarkers, medical imaging of the coronary and carotid vessel walls to evaluate the plaque characteristics, and atherosclerotic plaque bioassays.